ANAPTYSBIO, INC.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2017 | — | $307.6M | $81.2M |
| FY2018 | — | $486.4M | $113.6M |
| FY2019 | — | $405.0M | $171.0M |
| FY2020 | — | $396.7M | $250.5M |
| FY2021 | — | $356.4M | $495.7M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2017 | — | $307.6M | $81.2M |
| FY2018 | — | $486.4M | $113.6M |
| FY2019 | — | $405.0M | $171.0M |
| FY2020 | — | $396.7M | $250.5M |
| FY2021 | — | $356.4M | $495.7M |